TERESA SMITH: Open Payments
NPI 1629610126 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 28 payments from 12 companies in 2025. Trend: 2023 $1,308 · 2024 $1,099 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $259 |
| Novartis Pharmaceuticals Corporation | 7 | $110 |
| Boston Scientific Corporation | 3 | $96 |
| Alnylam Pharmaceuticals Inc. | 3 | $54 |
| Novo Nordisk Inc | 3 | $51 |
| Medtronic, Inc. | 1 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| PFIZER INC. | 1 | $15 |
Products named: REPATHA, LEQVIO, WATCHMAN FLX, AMVUTTRA, Wegovy, ELIQUIS, LINQ II, JARDIANCE.
Industry payments across MO — which companies pay providers there.
